期刊文献+

黄挺对甲状腺癌术后的辨证论治思路 被引量:26

HUANG Ting Exploring of the TCM Syndrome Differentiation-treatment for Thyroid Can-cer After Surgery
在线阅读 下载PDF
导出
摘要 介绍黄挺教授对甲状腺癌术后的中医辨证思路及治疗经验。黄挺教授从临床实践中发现,甲状腺癌多属虚实夹杂,在机体气阴两虚、气血不足甚或阴阳虚衰的基础上夹有气滞、痰凝、瘀毒内结。黄教授认为甲状腺癌术后辨证主要与中医阴虚火旺、气阴两虚以及痰瘀互结相关,并相应的采用滋阴清热、益气养阴、化痰行瘀等法治之,以提高中医对甲状腺癌术后中医调治的疗效。 This paper describes Professor HUANG Ting exploring the TCM syndrome differentiation-treatment for thyroid cancer after surgery . Professor HUANG Ting finds that thyroid cancer mostly Belonged to deficiency-excess complication from clinical practice. Causing of thyroid cancer is based on deficiency of both qi and yin or both qi and blood or even failure of both yin and yang, with qi stagnation, phlegm, blood stasis poison inside. Professor HUANG believes that the occurrence of thyroid cancer after surgery is relat- ed to pathogenesis such as fire excess due to yin deficiency , deficiency of both qi and yin and intermingled phlegm and blood stasis, and adopts corresponding treatment such as nourishing yin and clearing heat, nourishing qi and yin and resolving phlegm and removing blood stasis ,in order to improve the curative effect of traditional Chinese medicine to the treatment of thyroid cancer after surgery
作者 陈晓晓 黄挺
出处 《江西中医药大学学报》 2015年第1期25-28,共4页 Journal of Jiangxi University of Chinese Medicine
关键词 中医 甲状腺癌 辨证论治 肿瘤 Traditional Chinese Medicine Thyroid Cancer,Treatment Based on Syndrome Differentiation Cancer
作者简介 浙江中医药大学2012级硕士研究生 通信作者:黄挺(1967-),男,博士,主任医师。研究方向:中西医结合医学肿瘤。E-mail:huangtin100sohu.com。
  • 相关文献

参考文献2

二级参考文献17

  • 1吴敏华,陈亚男,刘艳清.周维顺主任医师治疗甲状腺癌经验[J].河南中医,2007,27(2):22-22. 被引量:16
  • 2Sherman SI. Thyroid carcinoma[ J]. Lancet,2003,361:501 -511.
  • 3Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J]. Thyroid ,2006 ,16 : 109 - 141.
  • 4Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium [ J ]. Eur J of Endocrinol, 2006,154 ( 6 ) : 787 - 803.
  • 5Sundram F, Robinson BG, Kung A, et al. Well-differentiated epithelial thyroid cancer management in the asia pacific region:a report and clinical practice guideline[ J]. Thyroid ,2006,16:461 -469.
  • 6Baloch Z,Carayon P, Conte-Devolx B,et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease [ J ]. Thyroid,2003,13:123 - 126.
  • 7Pacini F,Castagna MG, Brilli L, et al. Differentiated thyroid caneer:ESMO Clinical Recommendations for diagnosis, treatment and follow-up[ J ]. Ann Onco1,2009,19 ( Sup2 ) : 143 - 146.
  • 8Kloos RT. Papillary thyroid cancer:medical management and follow-up[ J ]. Curr Treat Options Onco1,2005 ,6 :328 - 338.
  • 9Barbaro D, Boni G. Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH:why,how and when[ J]. Eur J Surg Oncol,2007,33:535 -540.
  • 10Hackshaw A, Harmer C, Mallick U, et al. 131I activity for remnant ablation in patients with differentiated thyroid cancer:A systematic review[ J]. J Clin Endoerinol Metab,2007 ,92 :28 -38.

共引文献38

同被引文献314

引证文献26

二级引证文献169

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部